XML 21 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Cash, Cash Equivalents, and Marketable Securities (Tables)
12 Months Ended
Dec. 31, 2019
Investments Debt And Equity Securities [Abstract]  
Summary of Cash, Cash Equivalents, and Marketable Securities

The following tables summarizes the Company’s cash, cash equivalents and marketable securities as of December 31, 2019 and 2018.  

 

As of December 31, 2019

 

 

 

Amortized

Cost

 

 

Unrealized

Gain

 

 

Unrealized

(Loss)

 

 

Fair

Value

 

Cash and cash equivalents

 

$

13,564,252

 

 

$

 

 

$

(461

)

 

$

13,563,791

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury Bonds

 

 

10,494,539

 

 

 

811

 

 

 

 

 

 

10,495,350

 

Total marketable securities

 

$

10,494,539

 

 

$

811

 

 

$

 

 

$

10,495,350

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total cash, cash equivalents and marketable securities

 

$

24,058,791

 

 

$

811

 

 

$

(461

)

 

$

24,059,141

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2018

 

 

 

Amortized

Cost

 

 

Unrealized

Gain

 

 

Unrealized

(Loss)

 

 

Fair

Value

 

Cash and cash equivalents

 

$

7,600,284

 

 

$

 

 

$

 

 

$

7,600,284

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Debt Securities

 

$

18,961,145

 

 

$

 

 

$

(25,888

)

 

$

18,935,257

 

Commercial Paper

 

 

6,970,867

 

 

 

 

 

 

(4,927

)

 

 

6,965,940

 

U.S. Treasury Bonds

 

 

35,074,005

 

 

 

 

 

 

(12,115

)

 

 

35,061,890

 

Total marketable securities

 

$

61,006,017

 

 

$

 

 

$

(42,930

)

 

$

60,963,087

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total cash, cash equivalents and marketable securities

 

$

68,606,301

 

 

$

 

 

$

(42,930

)

 

$

68,563,371